TUCSON, AZ, and DOWNINGTOWN, PA – December 4, 2017 –Critical Path Institute‘s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) have announced that they will work together to develop an aggregated database of clinical data for Friedreich’s ataxia (FA). Use of this database will promote collaborative research to support the understanding of natural history, potential biomarkers, and potential clinical endpoints for patients with FA, which will help researchers develop more efficient clinical trial protocols to test new therapies more quickly and effectively.Continue reading
Category Archives: AZBio News
Dignity Health-Arizona Study Focuses on Teen Opioid Abuse
Two-Thirds of Parents See Teen Opioid Drug Abuse a Problem. Barrow Neurological Institute, part of Dignity Health St. Joseph’s Hospital and Medical Center, is developing an opioid education program that is similar to the successful Barrow Brainbook, which all Arizona high school student-athletes must pass before participating in sports. Continue reading
One-size treatment for blood cancer probably doesn’t fit all, researchers say
Most multiple myeloma studies involve people of European descent, but the disease is more likely to affect African-AmericansContinue reading
Dorothy Foundation donates to Biodesign Institute project to diagnose pancreatic cancer earlier
Last year, pancreatic cancer overtook breast cancer as the third leading cause of cancer deaths. WIth a five-year survival rate of just 8 percent, it is one of the deadliest forms of cancer.Continue reading
Mayo Clinic, ASU collaborate to seed and accelerate research
For 14 years, the Mayo Clinic and ASU seed grant program has been funding – or seeding –new research collaborations between ASU and Mayo Clinic researchers aimed at improving patient care. By launching novel research on a small scale, researchers have been able to attract funding needed for larger studies and are making significant impact in their fields of studyContinue reading
Cancer Prevention Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
CEO to give update on clinical pipeline and lead drug CPP-1X